PATENT CLAIM ANALYSIS

Application Number: 15905748
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "737000"]

Abstract:
Disclosed herein are compositions and methods for treating tauopathies such as Alzheimer's disease (AD). Also provided herein are methods of reducing or disrupting tau aggregation in a subject, and methods of reducing tau protein in a subject. The methods may include administering to the subject a therapeutic amount of hexachlorophene, or a pharmaceutically acceptable salt thereof. Further provided herein are pharmaceutical compositions comprising hexachlorophene, or a pharmaceutically acceptable salt thereof, for the treatment of a tauopathy in a subject.

Claim (Index 3):
A method of reducing tau protein in a subject, the method comprising administering to the subject a therapeutic amount of hexachlorophene, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 88.0
- Lexical Diversity: 1.83673
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15503636', '14486679', '15342629', '14271177', '14776924']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7186534909047191
- 35 USC 102 Novelty (BERT): 0.4858975829516078
- Combined Prediction Score: 0.6953779001094079
- Mean Citation Score: 236.049496
- Max Citation Score: 244.22226
- Similarity Product: 209.1195869072736

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test